When administering Lisinopril, key nursing considerations include monitoring patient status, checking critical laboratory values, and providing appropriate safety education. Unsafe practices such as stopping medications abruptly or doubling missed doses are incorrect.
In-depth explanation
Clinical reasoning summary
DHP CCB peripheral edema
Dihydropyridine CCBs (amlodipine, nifedipine, felodipine) cause selective arteriolar pre-capillary vasodilation without comparable post-capillary venous dilation, raising hydrostatic pressure in the capillary bed and producing dose-dependent, gravity-dependent peripheral edema (most often bilateral ankles, end-of-day worse, resolves overnight). It occurs in 5-15% of patients and is NOT volume overload — diuretics do not reliably reverse it. Standard management is dose reduction, addition of an ACE inhibitor or ARB (which dilates the venous side and counterbalances the hydrostatic pressure), or a switch to a non-DHP CCB or another antihypertensive class. The absence of dyspnea·orthopnea·weight gain·JVD makes acute heart failure unlikely, so an ED visit is not warranted but an outpatient evaluation is. Self-stopping the drug or substituting aspirin·high-salt diet is incorrect.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.